Alpha Tau Medical (NASDAQ:DRTS) vs. OrthoPediatrics (NASDAQ:KIDS) Financial Contrast

OrthoPediatrics (NASDAQ:KIDSGet Free Report) and Alpha Tau Medical (NASDAQ:DRTSGet Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation.

Insider & Institutional Ownership

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 31.8% of OrthoPediatrics shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and price targets for OrthoPediatrics and Alpha Tau Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics 1 1 9 0 2.73
Alpha Tau Medical 2 1 4 0 2.29

OrthoPediatrics currently has a consensus target price of $24.44, suggesting a potential upside of 18.03%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential upside of 3.34%. Given OrthoPediatrics’ stronger consensus rating and higher possible upside, research analysts clearly believe OrthoPediatrics is more favorable than Alpha Tau Medical.

Valuation & Earnings

This table compares OrthoPediatrics and Alpha Tau Medical”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OrthoPediatrics $236.35 million 2.25 -$39.65 million ($1.68) -12.33
Alpha Tau Medical N/A N/A -$42.63 million ($0.67) -18.20

OrthoPediatrics has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

OrthoPediatrics has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.

Profitability

This table compares OrthoPediatrics and Alpha Tau Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OrthoPediatrics -16.31% -7.01% -4.86%
Alpha Tau Medical N/A -73.23% -52.90%

Summary

OrthoPediatrics beats Alpha Tau Medical on 9 of the 13 factors compared between the two stocks.

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

About Alpha Tau Medical

(Get Free Report)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.